EULAR

EULAR
Name	EULAR
Formation	1947
Headquarters	Zurich, Switzerland
Type	International non-profit
Purpose	Research, advocacy, education in rheumatology
Leader title	President

EULAR is a major European network and umbrella organization bringing together scientific societies, patient organizations, health professionals, and industry partners in the field of rheumatology. It serves as a focal point for collaboration among clinicians, researchers, patient advocates, and regulatory bodies across Europe and beyond, linking national societies with international initiatives in musculoskeletal and connective tissue disease research. The organization interacts with policy forums, academic centers, and patient groups to shape clinical practice, research priorities, and education in rheumatology.

History

Founded shortly after World War II, EULAR emerged in a postwar period marked by reconstruction in Zurich and rebuilding of scientific collaboration across Europe. Its development paralleled the formation of regional bodies such as the Council of Europe and institutions like the World Health Organization that promoted cross-border health cooperation. During the Cold War era, interactions among rheumatology societies from countries including United Kingdom, France, Germany, Italy, Spain, Poland, Czechoslovakia, Hungary, Sweden, Norway and Finland fostered exchanges similar to those seen in networks linked to the European Union and the North Atlantic Treaty Organization. Over successive decades, EULAR engaged with academic centers such as University of Oxford, Karolinska Institute, Université Paris Descartes, University of Milan, Heidelberg University, University of Barcelona, University of Amsterdam, University of Copenhagen, University of Zürich, and Imperial College London to develop clinical recommendations and collaborative trials. Interactions with regulatory and research funders such as the European Commission, European Medicines Agency, National Institutes of Health, Wellcome Trust, European Research Council, and foundations like the Bill & Melinda Gates Foundation and European Foundation for Rheumatology shaped its research agenda. Milestones included major congresses, publication of consensus statements, and partnerships with journals and publishers such as The Lancet, New England Journal of Medicine, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, and BMJ.

Mission and Objectives

EULAR's mission aligns with promoting research, prevention, treatment, and rehabilitation for rheumatic and musculoskeletal diseases through collaboration with entities like the European Commission, World Health Organization, Council of Europe, European Parliament, American College of Rheumatology, International League Against Rheumatism, European Society of Cardiology, European Academy of Dermatology and Venereology, European Neurological Society, and patient organizations such as Arthritis Foundation, Versus Arthritis, Polish Rheumatology Society and numerous national charities. Objectives include developing clinical practice guidelines, advancing basic and translational research in partnership with universities like UCL', Trinity College Dublin, University of Edinburgh, Ghent University, and funding bodies including Horizon 2020 and Horizon Europe. The organization collaborates with specialty societies such as the European Alliance of Associations for Rheumatology, European Federation of Immunological Societies, European League Against Rheumatism-affiliated groups, and regulatory stakeholders including European Medicines Agency and national health ministries.

Organizational Structure

The governance model comprises elected leadership, committees, and working groups that interface with national societies from countries such as Belgium, Austria, Portugal, Greece, Romania, Bulgaria, Slovakia, Slovenia, Croatia and Lithuania. Committees include scientific, educational, and advocacy arms working alongside methodological groups interacting with trial networks at institutions like Mayo Clinic, Cleveland Clinic, Johns Hopkins University, Charité – Universitätsmedizin Berlin, St Thomas' Hospital, Royal Free Hospital, and research consortia funded by European Research Council grants. Partnerships extend to industry stakeholders, regulatory advisers from European Medicines Agency, ethics boards at universities such as University of Cambridge and Princeton University, and patient advisory committees modeled on groups like European Patients' Forum and International Alliance of Patients' Organizations.

Conferences and Events

EULAR organizes annual congresses and specialist meetings that attract delegates from institutions including Harvard Medical School, Stanford University School of Medicine, Yale School of Medicine, Massachusetts General Hospital, Royal Society, and national rheumatology societies of Ireland, Scotland, Wales, Israel, Turkey, Russia, Belarus, and Ukraine. These events feature sessions on clinical trials, translational science, and public health with speakers from journals such as Nature Medicine, Science Translational Medicine, Cell, and organizations like European Society for Clinical Microbiology and Infectious Diseases and International Society for Clinical Densitometry. Satellite symposia often involve professional bodies such as European Federation of Occupational Therapy and patient forums modeled on European Patient Forum.

Research, Guidelines, and Education

EULAR develops evidence-based recommendations and educational curricula in collaboration with universities and research institutes including Max Planck Society, Pasteur Institute, Institut Curie, Scripps Research, Broad Institute, Karolinska Institutet, Institut Pasteur de Lille, CNRS, and registries like European Medicines Agency-linked pharmacovigilance databases. Guideline development interfaces with specialty organizations such as the American College of Rheumatology, International Osteoporosis Foundation, European League Against Rheumatism committees, and methodological partners like Cochrane Collaboration and GRADE Working Group. Educational offerings include EULAR Courses, online modules, and fellowships that collaborate with training centers at University College London Hospitals, Guy's and St Thomas' NHS Foundation Trust, Royal Marsden Hospital, and research programs funded by Horizon Europe.

Advocacy and Patient Involvement

Advocacy initiatives engage with policy actors such as the European Parliament, European Commission, national health ministries, patient coalitions like European Patients' Forum, Arthritis Ireland, Versus Arthritis, Lupus Europe, Axial Spondyloarthritis Association and professional societies including British Society for Rheumatology, German Society for Rheumatology, French Society of Rheumatology and Italian Society for Rheumatology. Patient involvement is embedded through patient research partners, outcome measure development alongside groups like Outcome Measures in Rheumatology, and collaborations with health technology assessment agencies such as National Institute for Health and Care Excellence and Institut national de la santé et de la recherche médicale.

Membership and Affiliates

Membership encompasses national scientific societies, health professional associations, and patient organizations from countries across Europe and partner organizations worldwide including the American College of Rheumatology, Asia Pacific League of Associations for Rheumatology, Pan American League of Associations for Rheumatology, and academic centers such as University of Tokyo, Seoul National University, Monash University, University of Sydney, University of Toronto, McGill University, University of São Paulo, and University of Cape Town. Affiliate relationships include collaborations with journals, registries, research infrastructures like European Bioinformatics Institute, biobanks such as UK Biobank, and networks funded by frameworks like FP7 and Horizon 2020.

Category:Rheumatology organizations